• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [15931 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2014 Medical Services Advisory Committee (MSAC) Specialist dermatology services delivered by asynchronous store and forward technology
2014 Medical Services Advisory Committee (MSAC) Transcatheter occlusion of the left atrial appendage (LAA) for patients with non-valvular atrial fibrillation
2014 Medical Services Advisory Committee (MSAC) Second Opinion for Morphological/Interpretive Pathology
2014 Medical Services Advisory Committee (MSAC) Bone mineral density analyses using Dual Energy X-Ray Absorptiometry (DXA) in breast cancer patients receiving aromatase inhibitor treatment
2014 Medical Services Advisory Committee (MSAC) The removal of imbedded corneal foreign bodies by an optometrist
2014 Medical Services Advisory Committee (MSAC) Repetitive Transcranial Magnetic Stimulation (rTMS) for the treatment of depression
2014 Medical Services Advisory Committee (MSAC) Non-mydriatic retinal photography (NMP) in persons with diabetes
2014 Medical Services Advisory Committee (MSAC) Remote monitoring of patients with implanted cardiac devices (resubmission)
2014 Medical Services Advisory Committee (MSAC) Diagnostic fluorescence in situ hybridisation (FISH) testing for Anaplastic Lymphoma Kinase (ALK) in advanced non-small cell lung cancer (NSCLC) to determine eligibility for crizotinib treatment (co-dependent). (Resubmission)
2014 Health Council of the Netherlands Gezondheidsraad (GR) Penicillamine - Evaluation of the effects on reproduction, recommendation for classification
2014 Health Council of the Netherlands Gezondheidsraad (GR) 5-Nitroacenaphthene
2014 Health Council of the Netherlands Gezondheidsraad (GR) Mobile phones and cancer. Part 2. Animal studies on carcinogenesis
2014 Health Council of the Netherlands Gezondheidsraad (GR) Dimethyl sulphate. Health-based calculated occupational cancer risk values
2014 Health Council of the Netherlands Gezondheidsraad (GR) Fungal alpha-amylase (derived from the fungus Aspergillus oryzae)
2014 Health Council of the Netherlands Gezondheidsraad (GR) Acetaldehyde. Re-evaluation of the carcinogenicity and genotoxicity
2014 Health Council of the Netherlands Gezondheidsraad (GR) Fitness to drive requirements: some recommendations
2014 Health Council of the Netherlands Gezondheidsraad (GR) Employees and infectious diseases - criteria for vaccination
2014 Health Council of the Netherlands Gezondheidsraad (GR) Population Screening Act: first trimester scan for prenatal screening
2014 Health Council of the Netherlands Gezondheidsraad (GR) Population screening act: study into self-sampling as primary screening for cervical cancer
2014 NIHR Health Technology Assessment programme Interventions for central serous retinopathy: a network meta-analysis
2014 NIHR Health Technology Assessment programme Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolism [ID726]
2014 NIHR Health Technology Assessment programme Aflibercept solution for injection for treating diabetic macular oedema [ID717]
2014 NIHR Health Technology Assessment programme Dexamethasone intravitreal implant for treating diabetic macular oedema [ID653]
2014 NIHR Health Technology Assessment programme Vedolizumab for treating moderate to severe active Crohn's disease after prior therapy [ID690]
2014 Institute of Health Economics (IHE) Low dose computed tomography for the screening of lung cancer in adults
2014 Institute of Health Economics (IHE) First and second trimester prenatal screening update
2014 Institute of Health Economics (IHE) Endovenous ablation interventions for symptomatic varicose veins of the legs
2014 Institute of Health Economics (IHE) Hysteroscopic tubal sterilization
2014 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Miethke proSA® adjustable gravitational shunt for hydrocephalus
2014 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Drug-eluting stents with CD34 antibodies for the treatment of coronary artery disease
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacologic and non-pharmacologic treatments for alcohol withdrawal in the outpatient setting: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Long-term sustained clinical remission after stopping first-line anti-TNF agents in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis: clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with cognitive impairment associated with a neurological impairment: diagnostic accuracy
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Naloxone prescribing: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Developmental effects of in utero exposure to prescription drug abuse in infants and young children: harms
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Slow-release opioids for postoperative pain: clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Prolotherapy for the management of musculoskeletal pain: a review of the clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Brain electrical activity mapping for diagnosing psychiatric disorders: a review of the clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Aripiprazole for pregnant women: safety
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Neuro-linguistic programming for the treatment of adults with post-traumatic stress disorder, general anxiety disorder, or depression: a review of clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Locked units to limit access for dementia patients in long-term care facilities: clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Transcranial magnetic stimulation for the treatment of adults with PTSD, GAD, or depression: a review of clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening and risk stratification for diabetic foot ulcers: a review of clinical effectiveness, cost-effectiveness, and guidelines
2014 NIHR Public Health Research (PHR) programme Putting Life in Years (PLINY): a randomised controlled trial and mixed-methods process evaluation of a telephone friendship intervention to improve mental well-being in independently living older people
2014 NIHR Public Health Research (PHR) programme A pilot feasibility cluster randomised controlled trial of screening and brief alcohol intervention to prevent hazardous drinking in young people aged 14 15 years in a high school setting (SIPS JR-HIGH)
2014 NIHR Public Health Research (PHR) programme A pragmatic evaluation of a family-based intervention for childhood overweight and obesity
2014 NIHR Public Health Research (PHR) programme Does the Royal Horticultural Society Campaign for School Gardening increase intake of fruit and vegetables in children? Results from two randomised controlled trials
2014 NIHR Public Health Research (PHR) programme Outreach programmes for health improvement of Traveller Communities: a synthesis of evidence
2014 Institute for Clinical and Economic Review (ICER) Appropriate imaging for breast cancer screening in special populations
2014 Institute for Clinical and Economic Review (ICER) Proton beam therapy
2014 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [Development of composite indicators to measure the quality of prevention and chronic management activities for gynecological cancer screening in primary care]
2014 Agencia de Evaluacion de Tecnologias Sanitarias (AETS) [EndoBarrier® evaluation device for the treatment of morbid obesity with or without diabetes mellitus type II]
2014 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Centralisation of bariatric surgery: policy implications
2014 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Spinal surgery for chronic low back pain: review of clinical evidence and guidelines
2014 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Remote presence robots in telemedicine
2014 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Implantable carotid sinus baroreflex device for the treatment of drug-resistant hypertension
2014 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Online programs for weight loss
2014 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) HPV OncoTect™ E6, E7 mRNA assay to guide colposcopy referral in cervical cancer screening
2014 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Balloon sinuplasty for chronic rhinosinusitis
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Computed tomography imaging for the diagnosis of renal colic: a review of clinical and cost-effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Screening tools to identify adults with cognitive impairment associated with a cerebrovascular accident or traumatic brain injury: diagnostic accuracy
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Psychiatrist-led care of patients with dementia and psychiatric disorders in long-term care settings: clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Portable ultrasound devices for obstetrical or prenatal assessment in rural or remote settings: a review of the diagnostic accuracy
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Tramadol for the management of pain in adult patients: clinical effectiveness and guidelines
2014 Health Information and Quality Authority (HIQA) Health technology assessment (HTA) of public access defibrillation
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Tiotropium bromide
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Digital tomosynthesis for the screening and diagnosis of breast cancer: diagnostic accuracy and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Frequency of rescreening of patients negative for antibiotic resistant organisms: clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Intravenous administration of medications in home care settings: clinical evidence and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Urine testing in long-term care: clinical and cost effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Continuous positive airway pressure compared with oral devices or lifestyle changes for the treatment of obstructive sleep apnea: a review of the clinical and cost-effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Parent advisors in pediatric rehabilitation: clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Universal screening for antibiotic-resistant organisms in long-term care facilities: clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Linaclotide
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Dexmedetomidine for sedation in the ICU or PICU: a review of cost-effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Autologous blood reinfusion system for orthopedic surgery: clinical and cost-effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Extracorporeal membrane oxygenation for acute respiratory failure: a review of the clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D toxicity associated with different vitamin D dosing regimens: safety
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Extracorporeal membrane oxygenation for cardiac failure: a review of the clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Post-operative cerebrospinal fluid removal: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Islet cell transplantation in patients with unstable diabetes: a review of clinical- and cost-effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Azelastine - HCl and fluticasone propionate
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Urine testing in long-term care: guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Retinal surgeries in non-hospital facilities: clinical and cost-effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Immediate initiation of continuous positive airway pressure compared with delayed initiation: clinical effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Triple therapy for hepatitis C in previous non-responders: a review of the clinical effectiveness and safety
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Sofosbuvir for the treatment of patients with genotype 4 hepatitis C: a review of the clinical efficacy, cost-effectiveness, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Outpatient self-dialysis programs for patients with chronic renal conditions: clinical and cost-effectiveness, safety, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Foley catheter removal following hip surgery in elderly patients: benefits, harms, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) SYMBIS for neurosurgery and spine application: clinical and cost-effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Ombitasvir/paritaprevir/ritonavir and dasabuvir
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D testing in the general population: clinical and cost-effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D toxicity associated with different vitamin D dosing regimens: safety
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Transmission of infectious agents and risk of injury from patient transfer boards in healthcare settings: clinical evidence
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) NxStage home hemodialysis use in remote or rural settings with well water: clinical effectiveness, cost-effectiveness, and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Corneal cross-linking with riboflavin for keratoconus: update of clinical and cost-effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Ferumoxytol versus other intravenous iron therapies for anemia: a review of the clinical and cost-effectiveness and guidelines
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Antibacterial sutures for wound closure after surgery: a review of clinical and cost-effectiveness and guidelines for use
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Non-contact thermometers for detecting fever: a review of clinical effectiveness
2014 Canadian Agency for Drugs and Technologies in Health (CADTH) Mass thermography screening for infection and prevention: a review of the clinical effectiveness